Financial Services
Live Price
Offline$10.64
+0.00% today
1Y Change
+4.52%
Window
Jun 26, 2025 → Jun 25, 2026
Coverage: 250 bars · Jun 26, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) is a Financial Services stock with a market cap of $360.00M and listed on NASDAQ. The stock last traded around $10.64 and up 4.5% across the available one-year price window (Jun 26, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +439.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +439.3%, free cash flow -182675.3% with operating margin 0.0% and ROIC -1.2%. Valuation already assumes a fairly strong business story at P/E 37.4. Stock Foundry combines DMAA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DMAA
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DMAA Max Drawdown
-0.49%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for DMAA and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.